NEA Management Company’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.75M | Hold |
|
|||||
|
2025
Q1 | $2.22M | Hold |
|
|||||
|
2024
Q4 | $6.75M | Hold |
|
|||||
|
2024
Q3 | $12.7M | Hold |
|
|||||
|
2024
Q2 | $10.9M | Hold |
|
|||||
|
2024
Q1 | $18.7M | Hold |
|
|||||
|
2023
Q4 | $10.4M | Hold |
|
|||||
|
2023
Q3 | $10.2M | Hold |
|
|||||
|
2023
Q2 | $13.6M | Hold |
|
|||||
|
2023
Q1 | $14M | Hold |
|
|||||
|
2022
Q4 | $2.56M | Sell |
|
|||||
|
2022
Q3 | $6.55M | Hold |
|
|||||
|
2022
Q2 | $10.5M | Hold |
|
|||||
|
2022
Q1 | $10M | Hold |
|
|||||
|
2021
Q4 | $16.7M | Hold |
|
|||||
|
2021
Q3 | $28.3M | Hold |
|
|||||
|
2021
Q2 | $41.7M | Hold |
|
|||||
|
2021
Q1 | $48.4M | Hold |
|
|||||
|
2020
Q4 | $50.5M | Hold |
|
|||||
|
2020
Q3 | $64.3M | Buy |
|